Delayed Prostate Cancer Therapy La Plata MD

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Krishan Murari Mathur, MD
(301) 843-6040
PO Box 2729
La Plata, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: S M S Med Coll, Univ Of Rajasthan, Jaipur, Rajasthan, India
Graduation Year: 1977

Data Provided by:
Boris Naydich, MD
(301) 705-5802
11340 Pembrooke Sq Ste 201
Waldorf, MD
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Kemerovskij Med Inst, Kemerovo, Russia
Graduation Year: 1973

Data Provided by:
Ashima Saini
(301) 705-5802
11340 Pembrooke Sq
Waldorf, MD
Specialty
Radiation Oncology

Data Provided by:
Ashima Saini, MD
(414) 352-3100
30077 Business Center Dr
Charlotte Hall, MD
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Univ Of Md Sch Of Med, Baltimore Md 21201
Graduation Year: 1986

Data Provided by:
Oliver Alabaster, MD
Alexandria, VA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Charing Cross And Westminster Med Sch, London (352-07 Pr 01/71)
Graduation Year: 1966

Data Provided by:
Krishan Mathu, MD
(301) 645-4242
3500 Old Washington Rd Ste 102
Waldorf, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
M Ashraf Meelu, MD
(301) 638-1007
10 Saint Patricks Dr Ste 408
Waldorf, MD
Specialties
Oncology (Cancer)
Gender
Male
Languages
Panjabi, Urdu
Education
Medical School: Punjab Med Coll, Univ Of Punjab, Faisalabad, Pakistan
Graduation Year: 1980
Hospital
Hospital: St Marys Hospital, Leonardtown, Md; Southern Maryland Hospital, Clinton, Md; Calvert Mem Hosp, Prnc Frederck, Md; Civista Med Ctr, La Plata, Md; Ft Washington Med Ctr, Ft Washington, Md
Group Practice: Southern Maryland Oncology

Data Provided by:
Karen Jane Hoffmeister, DO
Waldorf, MD
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Philadelphia Coll Of Osteo Med, Philadelphia Pa 19131
Graduation Year: 1984

Data Provided by:
Sarah A Leonhard
(301) 888-2233
13605 Baden Westwood Road
Brandywine, MD
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Deepnarayan Tiwarri
(301) 868-7911
8926 Woodyard Rd
Clinton, MD
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Data Provided by:

Delayed Prostate Cancer Therapy

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com